These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20090910)

  • 1. Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males.
    Sansom SL; Prabhu VS; Hutchinson AB; An Q; Hall HI; Shrestha RK; Lasry A; Taylor AW
    PLoS One; 2010 Jan; 5(1):e8723. PubMed ID: 20090910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
    Binagwaho A; Pegurri E; Muita J; Bertozzi S
    PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis.
    Haacker M; Fraser-Hurt N; Gorgens M
    PLoS Med; 2016 May; 13(5):e1002012. PubMed ID: 27138961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of Medicaid savings: the potential detrimental public health impact of neonatal circumcision defunding.
    Andrews AL; Lazenby GB; Unal ER; Simpson KN
    Infect Dis Obstet Gynecol; 2012; 2012():540295. PubMed ID: 23125519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male circumcision for prevention of heterosexual acquisition of HIV in men.
    Siegfried N; Muller M; Volmink J; Deeks J; Egger M; Low N; Weiss H; Walker S; Williamson P
    Cochrane Database Syst Rev; 2003; (3):CD003362. PubMed ID: 12917962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male circumcision for prevention of heterosexual acquisition of HIV in men.
    Siegfried N; Muller M; Deeks JJ; Volmink J
    Cochrane Database Syst Rev; 2009 Apr; (2):CD003362. PubMed ID: 19370585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
    Long EF; Stavert RR
    J Gen Intern Med; 2013 Oct; 28(10):1294-301. PubMed ID: 23588668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-utility analysis of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a probabilistic decision model.
    Uthman OA; Popoola TA; Yahaya I; Uthman MM; Aremu O
    Value Health; 2011 Jan; 14(1):70-9. PubMed ID: 21211488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
    White RG; Glynn JR; Orroth KK; Freeman EE; Bakker R; Weiss HA; Kumaranayake L; Habbema JD; Buvé A; Hayes RJ
    AIDS; 2008 Sep; 22(14):1841-50. PubMed ID: 18753931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus in African American heterosexual males: the roles of age and male circumcision.
    Van Wagoner NJ; Geisler WM; Sizemore JM; Whitley R; Hook EW
    Sex Transm Dis; 2010 Apr; 37(4):217-22. PubMed ID: 19910861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumcision rates in the United States: rising or falling? What effect might the new affirmative pediatric policy statement have?
    Morris BJ; Bailis SA; Wiswell TE
    Mayo Clin Proc; 2014 May; 89(5):677-86. PubMed ID: 24702735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of circumcision among men and boys aged 14 to 59 years in the United States, National Health and Nutrition Examination Surveys 2005-2010.
    Introcaso CE; Xu F; Kilmarx PH; Zaidi A; Markowitz LE
    Sex Transm Dis; 2013 Jul; 40(7):521-5. PubMed ID: 23965763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of male circumcision for HIV prevention in a South African setting.
    Kahn JG; Marseille E; Auvert B
    PLoS Med; 2006 Dec; 3(12):e517. PubMed ID: 17194197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of adult circumcision in a resource-rich setting for HIV prevention among men who have sex with men.
    Anderson J; Wilson D; Templeton DJ; Grulich A; Carter R; Kaldor J
    J Infect Dis; 2009 Dec; 200(12):1803-12. PubMed ID: 19909084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumcision: a decision analysis of its medical value.
    Lawler FH; Bisonni RS; Holtgrave DR
    Fam Med; 1991; 23(8):587-93. PubMed ID: 1794670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life.
    Schoen EJ; Colby CJ; Ray GT
    Pediatrics; 2000 Apr; 105(4 Pt 1):789-93. PubMed ID: 10742321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of sexual risk behaviours and HIV seroprevalence among circumcised and uncircumcised men before and after implementation of the safe male circumcision programme in Uganda.
    Kibira SP; Sandøy IF; Daniel M; Atuyambe LM; Makumbi FE
    BMC Public Health; 2016 Jan; 16():7. PubMed ID: 26727935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Pre-Exposure Prophylaxis Among Adolescent Sexual Minority Males.
    Wang LY; Hamilton DT; Rosenberg ES; Aslam MV; Sullivan PS; Katz DA; Dunville RL; Barrios LC; Goodreau SM
    J Adolesc Health; 2020 Jan; 66(1):100-106. PubMed ID: 31757626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of newborn circumcision to prevent HIV infection in the United States.
    Gust DA; Kretsinger K; Gaul Z; Pals S; Heffelfinger JD; Begley E; Chen RT; Kilmarx PH
    Sex Transm Dis; 2011 Jun; 38(6):536-42. PubMed ID: 21217414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.
    Mauskopf J; Brogan A; Martin S; Smets E
    Pharmacoeconomics; 2010; 28 Suppl 1():83-105. PubMed ID: 21182346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.